Loading…
Zhongchao Inc. is projected to decline to $0.9283 by 2027, a -18% move from its current price of $1.13. ZCMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.9905 | $1.13 | $1.29 | -0.09% |
| Aug 6 | $0.9373 | $1.13 | $1.36 | -0.19% |
| Aug 7 | $0.8983 | $1.13 | $1.41 | -0.28% |
| Aug 8 | $0.8665 | $1.13 | $1.46 | -0.37% |
| Aug 9 | $0.8394 | $1.12 | $1.51 | -0.47% |
| Aug 10 | $0.8155 | $1.12 | $1.55 | -0.56% |
| Aug 11 | $0.7941 | $1.12 | $1.59 | -0.65% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7941 | $1.12 | $1.59 | -0.65% |
| Week 2 | $0.6835 | $1.12 | $1.82 | -1.30% |
| Week 3 | $0.6083 | $1.11 | $2.02 | -1.95% |
| Week 4 | $0.5508 | $1.10 | $2.20 | -2.59% |
| Week 5 | $0.5042 | $1.09 | $2.37 | -3.23% |
| Week 6 | $0.4652 | $1.09 | $2.54 | -3.86% |
| Week 7 | $0.4318 | $1.08 | $2.70 | -4.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People’s Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs.
The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program.
It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Zhongchao Inc. trades in the Healthcare sector with current price $1.13 and a market capitalization of $6.96M, ranking 5185. Its current price and market position reflect a micro-cap healthcare player focused on information, education, and training services for medical professionals in China.
The stock’s near-term outlook is shaped by a 30-day technical picture that sits in a neutral zone and a wide range of forecasted annual prices that show both headwinds and potential longer-term upside. In the near term, the model projects muted gains in 2026, followed by more meaningful upside in the 2030s and a substantial rise by 2050.
A major floor 96.8% below — a decisive break under it would weaken the trend.
The nearest floor, 15.6% below — buyers have tended to step in here.
The nearest ceiling, 279.6% above — a clean break opens room to run.
A major ceiling 420.8% above — clearing it would confirm fresh momentum.
Key ZCMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZCMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.17 | Sell | $1.27 | Sell |
| MA 10 | $1.62 | Sell | $1.44 | Sell |
| MA 20 | $1.77 | Sell | $1.49 | Sell |
| MA 50 | $1.15 | Sell | $1.44 | Sell |
| MA 100 | $1.51 | Sell | $1.78 | Sell |
| MA 200 | $2.80 | Sell | $3.19 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.76 | Neutral |
| Stoch RSI (14) | 2.32 | Buy |
| CCI (20) | -92.08 | Neutral |
| Williams %R (14) | -97.83 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | -31.52 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 2.17 | Buy |
| TRIX (15) | 1.71 | Buy |
| Awesome (5,34) | -0.16 | Sell |
| Ultimate (7,14,28) | 24.49 | Buy |
| Momentum (10) | -0.47 | Sell |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 0.90 | Buy |
| ADX (14) | 16.32 | Neutral |
| ATR (14) | 0.40 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 30. The stock’s short-term momentum is cautious and lacks overbought strength. The SMA50 is $17.04 and the SMA200 is $237.93, indicating a long-term average price path well above current levels.
Near-term support is at $0.954 and resistance at $4.29, with a 30-day price range from $0.42 to $3.04. The combination suggests limited near-term upside momentum but a defined trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.954 | $1.13 | $1.40 | 0% | Neutral | |
| $0.6765 | $0.9283 | $1.38 | -18% | Bearish | |
| $0.5646 | $0.824 | $1.30 | -27% | Bearish | |
| $0.635 | $0.9766 | $1.62 | -14% | Neutral | |
| $0.739 | $1.19 | $2.06 | +5% | Neutral | |
| $0.8237 | $1.39 | $2.49 | +23% | Bullish | |
| $0.7366 | $1.30 | $2.40 | +15% | Neutral | |
| $0.5482 | $1.00 | $1.91 | -11% | Neutral | |
| $0.6062 | $1.16 | $2.25 | +2% | Neutral | |
| $0.6012 | $1.19 | $2.38 | +5% | Neutral | |
| $0.7114 | $1.58 | $3.47 | +40% | Bullish | |
| $1.53 | $3.39 | $7.81 | +200% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.954 | $1.13 | $1.36 | +0.00% |
| September 2026 | $0.8451 | $1.03 | $1.30 | -9.09% |
| October 2026 | $0.8417 | $1.04 | $1.34 | +0.98% |
| November 2026 | $0.873 | $1.09 | $1.43 | +4.91% |
| December 2026 | $0.8329 | $1.05 | $1.40 | -3.59% |
Click any year to see its month-by-month ZCMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ZCMD price prediction for 2026 points to an average of $1.13 (low $0.954, high $1.40) — a potential gain of 0% on today's $1.13. A consolidation phase looks the most probable path here.
In 2027, ZCMD is projected to trade between $0.6765 and $1.38, averaging $0.9283 — a potential decline of -18% from today's $1.13. That is -18% versus the projected 2026 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Zhongchao Inc.'s 2028 outlook centres on $0.824, within a $0.5646 to $1.30 range. That is -11% versus the projected 2027 average. That marks a -27% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2029, ZCMD could reach as high as $1.62, with a base case around $0.9766 and support toward $0.635 — roughly -14% from $1.13. Price action looks broadly range-bound.
Expect ZCMD to range from $0.739 to $2.06 through 2030. The $1.19 average target implies a +5% move from current prices. That is up +22% on the projected 2029 average. A consolidation phase looks the most probable path here.
The ZCMD price prediction for 2031 points to an average of $1.39 (low $0.8237, high $2.49) — a potential gain of +23% on today's $1.13. Momentum favours further upside here.
In 2032, ZCMD is projected to trade between $0.7366 and $2.40, averaging $1.30 — a potential gain of +15% from today's $1.13. That is -7% versus the projected 2031 average. A consolidation phase looks the most probable path here.
Zhongchao Inc.'s 2033 outlook centres on $1.00, within a $0.5482 to $1.91 range. That is -22% versus the projected 2032 average. That marks a -11% change versus current levels. Price action looks broadly range-bound.
By 2034, ZCMD could reach as high as $2.25, with a base case around $1.16 and support toward $0.6062 — roughly +2% from $1.13. A consolidation phase looks the most probable path here.
Expect ZCMD to range from $0.6012 to $2.38 through 2035. The $1.19 average target implies a +5% move from current prices. That is up +3% on the projected 2034 average. Price action looks broadly range-bound.
The ZCMD price prediction for 2040 points to an average of $1.58 (low $0.7114, high $3.47) — a potential gain of +40% on today's $1.13. Buyers look set to stay in control over this stretch.
In 2050, ZCMD is projected to trade between $1.53 and $7.81, averaging $3.39 — a potential gain of +200% from today's $1.13. That is up +115% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ZCMD today (≈ 884.955752 ZCMD) could be worth
$3,003.54
+$2,003.54 (+200%) by 2050 · US Dollar
Based on the average projected ZCMD price of $3.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZCMDwould be worth at today's price.
$1,000 invested in ZCMD on Jul 31, 2025 (≈ 121.713735 ZCMD) would be worth
$137.54
-$862.46 (-86.2%) today · 0.14× · US Dollar
Based on a ZCMD entry price of $8.22 vs. today's $1.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.4 | $807.14 | -19.3% |
| 1 month ago | $1.12 | $1,008.93 | +0.9% |
| 3 months ago | $2.13 | $530.52 | -46.9% |
| 6 months ago | $3.6 | $313.89 | -68.6% |
| 1 year ago | $8.22 | $137.54 | -86.2% |
| All time (5.0y) ago | $135.2 | $8.36 | -99.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZCMD forecast.
Our base-case forecast reaches $2.30 around 2050.
Implied market cap at $2.30: $13.68M
The multi-year forecast shows a mix of near-term caution and longer-term upside. For 2030, the average price is $1.20 with a 5.8% ROI (positive but modest) and a NEUTRAL sentiment. The following year, 2031, carries a stronger upside with an average of $1.39 and a 22.9% ROI, with a BEARISH-to-BULLISH shift reflected in a BUllISH sentiment.
The path then remains mixed through 2032–2035, with 2032 at $1.29 (14.3%), 2033 at $1.01 (-11%), 2034 at $1.16 (2.3%), and 2035 at $1.19 (5.2%). The forecast accelerates into the 2040s, where 2040 shows an average of $1.58 and a 39.9% ROI with a BULLISH sentiment, and by 2050 the average reaches $3.39 with a 199.9% ROI and a BULLISH sentiment. These figures imply substantial upside potential into the late 2040s and 2050, albeit with notable volatility in the intermediate years.
Investors should note the volatility in earlier years (e.g., 2027: avg $0.93 with -17.7% ROI and BEARISH sentiment; 2028: avg $0.82 with -27.1% ROI) and the larger upside in the long term. The outlook remains uncertain and is not a guarantee, with higher potential returns accompanied by higher risk as suggested by the sequence of sentiment labels and ROI figures.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.20 with ROI 5.8 and sentiment NEUTRAL.
Forecasts show mixed sentiment: neutral in 2026, bearish in 2027–2028, neutral in 2029–2032, and bullish in 2031, 2040, and 2050 with notably higher ROIs in those later years (e.g., 22.9% in 2031, 39.9% in 2040, and 199.9% in 2050). These are estimates, not guarantees, and risk remains.
The maximums in the forecast show $2.49 in 2031, $3.47 in 2040, and $7.79 in 2050, indicating that $5 could be approached in the very long term per the forecast, but it is not guaranteed.
The 30-day picture is NEUTRAL with RSI 30, SMA50 $17.04, SMA200 $237.93, support $0.954, resistance $4.29, and a 30-day range of $0.42 to $3.04.
Current price is $1.13 and market cap is $6.96M.
Zhongchao Inc. Community Discussion
0Share your Zhongchao Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.